Leo Cheung, Shiquan Wu, Brendan Hodkinson, Constantine Tam, William Wierda, Paolo Ghia, Anita Szoke, Edith Szafer Glusman. "First-line ibrutinib + venetoclax shows benefit across genomic subgroups in patients with chronic lymphocytic leukemia (CLL): Results from Phase 2 captivate study and Phase 3 glow study." Blood, 2025. doi:10.1182/blood-2025-5672